Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

438
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
438
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

675
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
675

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decomposing gender gaps in HIV service outcomes.

BMJ global health·2026
Same author

Formulation and validation of a regional household wealth index for sub-Saharan Africa.

PloS one·2025
Same author

A hybrid simulation model of HIV program interventions: from transmission behavior to macroeconomic impacts.

Therapeutic advances in drug safety·2025
Same author

American clusters: using machine learning to understand health and health care disparities in the United States.

Health affairs scholar·2024
Same author

Assessing the impact of the president's emergency plan for AIDS relief on all-cause mortality.

PLOS global public health·2024
Same author

Analysis of economic and educational spillover effects in PEPFAR countries.

PloS one·2023

Related Experiment Video

Updated: Dec 19, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K

Predicting Onset of Dementia Using Clinical Notes and Machine Learning: Case-Control Study.

Christopher A Hane1, Vijay S Nori1, William H Crown1

  • 1OptumLabs, Optum, Cambridge, MA, United States.

JMIR Medical Informatics
|June 4, 2020
PubMed
Summary

De-identified clinical notes significantly improve Alzheimer disease and related dementias (ADRD) risk prediction models. Incorporating these notes enhances machine learning accuracy for early ADRD detection and patient recruitment.

Keywords:
Alzheimer diseasedementiahealth information interoperabilityhealth information systemsmachine learningnatural language processing

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.4K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.8K

Related Experiment Videos

Last Updated: Dec 19, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.4K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.8K

Area of Science:

  • Medical Informatics
  • Machine Learning in Healthcare
  • Neurodegenerative Disease Research

Background:

  • Efficient tools are needed for recruiting patients at risk of Alzheimer disease and related dementias (ADRD).
  • Early ADRD detection aids patients in financial planning for long-term care.
  • Clinical notes are an underutilized data source for machine learning due to collection costs and analysis complexity.

Purpose of the Study:

  • To investigate the use of de-identified clinical notes from multiple hospital systems to augment retrospective machine learning models for ADRD risk.
  • To assess the impact of incorporating 10 years of clinical note data on ADRD prediction accuracy.

Main Methods:

  • Utilized 2 years of de-identified clinical note data to predict future ADRD onset.
  • Embedded clinical note terms into a 100-dimensional vector space to identify clusters and differences across hospital systems.
  • Employed natural language processing and postprocessing techniques to merge notes from multiple hospital systems.

Main Results:

  • Machine learning models incorporating clinical notes showed improved Area Under the Curve (AUC) from 0.85 to 0.94.
  • Positive Predictive Value (PPV) increased from 45.07% to 68.32% at disease onset when clinical notes were used.
  • Models demonstrated improved AUC and PPV in years 3-6, with mixed results in later years due to smaller cohort sizes.

Conclusions:

  • De-identified clinical notes enhance the accuracy of ADRD risk prediction models.
  • The presence of symptomatic terms years before diagnosis suggests undercoding of ADRD by clinicians.
  • Natural language processing of multi-system clinical notes can be effectively merged to improve model performance.